SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
|12 Months Ended|
Apr. 30, 2019
|SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]|
|SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS||
PHARMACYTE BIOTECH, INC.
Years Ended April 30, 2019 and 2018
The entire disclosure for valuation and qualifying accounts and reserves.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef